Soume Bhattacharya1, Brooke Read2, Evelyn McGovern3, Orlando da Silva1. 1. Children's Hospital, London Health Science Centre, Department of Pediatrics, Western University, London, Ontario. 2. Department of Respiratory Therapy, London Health Sciences Center, London, Ontario. 3. Neonatal Intensive Care Unit, London Health Science Centre, London, Ontario.
Abstract
BACKGROUND: Surfactant delivery via a thin endotracheal catheter during spontaneous breathing, a technique called minimally invasive surfactant therapy (MIST), is an alternative to intubation and surfactant administration. There is paucity of data regarding the administration of high-volume surfactant using this technique. METHODS: We conducted a retrospective cohort study to review the safety, efficacy, and procedural details pertaining to the delivery of 5 mL/kg of BLES® via MIST approach. In 2016, our centre initiated a practice change allowing the use of MIST as an alternative method of surfactant delivery in infants born at ≥28 weeks and/or with a birth weight ≥ 1,000 g with respiratory distress syndrome. In this study, we identified all neonates who received surfactant via MIST between May 1, 2016 and July 30, 2018 and collected relevant procedural data. RESULTS: Since this practice change, MIST technique was attempted in 43 neonates with successful instillation of surfactant in 41 (95.3%) of the neonates. Intubation and positive pressure ventilation was avoided in 35 neonates (85.3%). No serious adverse effect was noted. CONCLUSIONS: Our study reports successful use of higher volume surfactant via MIST. This should encourage other similar centres to consider this technique, in order to avoid unnecessary intubation and positive pressure ventilation.
BACKGROUND: Surfactant delivery via a thin endotracheal catheter during spontaneous breathing, a technique called minimally invasive surfactant therapy (MIST), is an alternative to intubation and surfactant administration. There is paucity of data regarding the administration of high-volume surfactant using this technique. METHODS: We conducted a retrospective cohort study to review the safety, efficacy, and procedural details pertaining to the delivery of 5 mL/kg of BLES® via MIST approach. In 2016, our centre initiated a practice change allowing the use of MIST as an alternative method of surfactant delivery in infants born at ≥28 weeks and/or with a birth weight ≥ 1,000 g with respiratory distress syndrome. In this study, we identified all neonates who received surfactant via MIST between May 1, 2016 and July 30, 2018 and collected relevant procedural data. RESULTS: Since this practice change, MIST technique was attempted in 43 neonates with successful instillation of surfactant in 41 (95.3%) of the neonates. Intubation and positive pressure ventilation was avoided in 35 neonates (85.3%). No serious adverse effect was noted. CONCLUSIONS: Our study reports successful use of higher volume surfactant via MIST. This should encourage other similar centres to consider this technique, in order to avoid unnecessary intubation and positive pressure ventilation.
Authors: Peter A Dargaville; Ajit Aiyappan; Anita Cornelius; Christopher Williams; Antonio G De Paoli Journal: Arch Dis Child Fetal Neonatal Ed Date: 2010-10-21 Impact factor: 5.747
Authors: Michael S Dunn; Joseph Kaempf; Alan de Klerk; Rose de Klerk; Maureen Reilly; Diantha Howard; Karla Ferrelli; Jeanette O'Conor; Roger F Soll Journal: Pediatrics Date: 2011-10-24 Impact factor: 7.124
Authors: Wolfgang Göpel; Angela Kribs; Andreas Ziegler; Reinhard Laux; Thomas Hoehn; Christian Wieg; Jens Siegel; Stefan Avenarius; Axel von der Wense; Matthias Vochem; Peter Groneck; Ursula Weller; Jens Möller; Christoph Härtel; Sebastian Haller; Bernhard Roth; Egbert Herting Journal: Lancet Date: 2011-09-29 Impact factor: 79.321
Authors: Peter A Dargaville; Ajit Aiyappan; Antonio G De Paoli; Carl A Kuschel; C Omar F Kamlin; John B Carlin; Peter G Davis Journal: Arch Dis Child Fetal Neonatal Ed Date: 2012-06-09 Impact factor: 5.747
Authors: Angela Kribs; C Härtel; E Kattner; M Vochem; H Küster; J Möller; D Müller; H Segerer; C Wieg; C Gebauer; W Nikischin; A v d Wense; E Herting; B Roth; W Göpel Journal: Klin Padiatr Date: 2010-01-18 Impact factor: 1.349